These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11872233)

  • 1. Alloresponses of cord blood cells in primary mixed lymphocyte cultures.
    Slavcev A; Stríz I; Ivasková E; Breur-Vriesendorp BS
    Hum Immunol; 2002 Mar; 63(3):155-63. PubMed ID: 11872233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses by cord blood cells.
    Roncarolo MG; Bigler M; Ciuti E; Martino S; Tovo PA
    Blood Cells; 1994; 20(2-3):573-85; discussion 585-6. PubMed ID: 7749123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model.
    Wang XN; Sviland L; Ademokun AJ; Dunn J; Cavanagh G; Proctor SJ; Dickinson AM
    Transplantation; 1998 Oct; 66(7):903-9. PubMed ID: 9798701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens.
    Falkenburg JH; van Luxemburg-Heijs SA; Lim FT; Kanhai HH; Willemze R
    Ann Hematol; 1996 Apr; 72(4):260-4. PubMed ID: 8624381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-enhanced mixed lymphocyte reaction (MLR) in cord blood.
    Umemoto M; Azuma E; Hirayama M; Nagai M; Hiratake S; Qi J; Kumamoto T; Kobayashi M; Komada Y; Sakurai M
    Clin Exp Immunol; 1998 Jun; 112(3):459-63. PubMed ID: 9649215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.
    Risdon G; Gaddy J; Stehman FB; Broxmeyer HE
    Cell Immunol; 1994 Mar; 154(1):14-24. PubMed ID: 8118883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation.
    Moretta A; Andriolo G; Lisini D; Martinetti M; Pasi A; Rebulla P; Soligo D; Giordano R; Lazzari L; Maccario R
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1108-18. PubMed ID: 22227591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained expression of CD154 (CD40L) and proinflammatory cytokine production by alloantigen-stimulated umbilical cord blood T cells.
    Matthews NC; Wadhwa M; Bird C; Borras FE; Navarrete CV
    J Immunol; 2000 Jun; 164(12):6206-12. PubMed ID: 10843672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic women show reduced T helper type 1 alloresponses to fetal human leucocyte antigen mismatch during pregnancy.
    Prescott SL; Breckler LA; Witt CS; Smith L; Dunstan JA; Christiansen FT
    Clin Exp Immunol; 2010 Jan; 159(1):65-72. PubMed ID: 19860744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal (cord blood) T cells can competently raise type 1 and 2 immune responses upon polyclonal activation.
    Chipeta J; Komada Y; Zhang XL; Azuma E; Yamamoto H; Sakurai M
    Cell Immunol; 2000 Nov; 205(2):110-9. PubMed ID: 11104583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of decreased interleukin 2 (IL-2) responsiveness and IL-2 production in autologous mixed-lymphocyte reaction of cord blood lymphocytes by interferon-gamma and IL-2 and the role of HLA-DQ antigen.
    Kawano Y; Noma T; Yata J
    Cell Immunol; 1987 Nov; 110(1):56-67. PubMed ID: 2960462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host disease.
    Imami N; Brookes PA; Lombardi G; Hakooz B; Johns M; Goldman JM; Batchelor JR; Lechler RI; Ritter MA
    Transplantation; 1998 Apr; 65(7):979-88. PubMed ID: 9565104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the cytotoxic alloresponse of cord blood.
    Barbey C; Irion O; Helg C; Chapuis B; Grand C; Chizzolini C; Jeannet M; Roosnek E
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S26-30. PubMed ID: 9715879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity of umbilical cord blood mononuclear cells: specific hyporesponse to noninherited maternal antigens.
    Tsafrir A; Brautbar C; Nagler A; Elchalal U; Miller K; Bishara A
    Hum Immunol; 2000 Jun; 61(6):548-54. PubMed ID: 10825582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage colony stimulating factor (M-CSF) within cord blood sera may be partially responsible for the reduced proliferation of cord blood T cells.
    Cohen SB; Woolley J; Bogunia-Kubik K; Natarajan P; Kotecha R; Belaramani L; Fallen PR; Perez-Cruz I; Madrigal JA
    Eur Cytokine Netw; 2000 Dec; 11(4):608-17. PubMed ID: 11125304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis.
    Bishop GA; Waugh JA; Hall BM
    Transplantation; 1988 Aug; 46(2):303-10. PubMed ID: 2970135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease.
    Harris DT; LoCascio J; Besencon FJ
    Bone Marrow Transplant; 1994 Oct; 14(4):545-53. PubMed ID: 7858529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional aspects of cord blood lymphocytes response to polyclonal and allogeneic activation.
    Paiva A; Freitas A; Loureiro A; Couceiro A; Martinho A; Simões O; Santos P; Tomaz J; Pais ML; Brêda Coimbra H
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S31-4. PubMed ID: 9715880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
    Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.